Invivyd, Inc.

IVVD

NASDAQ

Healthcare

Biotechnology

Waltham, MA, US99 employeesadagiotx.com

$1.32

+0.04(3.5%)

52W $0.47 – $2.88

AI-generated from 10-K FY2025 filed Mar 4, 2026

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United...

Revenue breakdown: Product (100%).

$176MMkt Cap

$41MRev TTM

-$40MNI TTM

-4.9xP/E TTM

Latest Earnings

10-K

FY FY2025Mar 4, 2026

10-K for FY2025 was filed on 2026-03-05. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Financial ResultsMar 4, 2026

. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities E

View filing →

Financial ResultsJan 7, 2026

. Item 8.01 Other Events. On January 8, 2026, the Company issued the Press Release, a copy of which is filed herewith as Exhibit 99.1 and is incorporated by ref

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Product100%($79M)

Peer Companies

Company	Price	Change	Market Cap	P/E
SLSSELLAS Life Sciences Grou...	$4.42	+7.14%	$630M	-31.2
GNFTGenfit S.A.	$8.95	+4.07%	$446M	-11.6
OBIOOrchestra BioMed Holdings...	$4.36	+2.11%	$255M	-3.5
CCCCC4 Therapeutics, Inc.	$2.93	+3.90%	$243M	-2.0
TARAProtara Therapeutics, Inc...	$5.12	+0.10%	$197M	-4.1
OABIOmniAb, Inc.	$1.53	-0.32%	$175M	-3.5
CDXSCodexis, Inc.	$1.91	+4.95%	$174M	-3.3
NTHINeonc Technologies Holdin...	$6.08	+2.27%	$122M	-2.9

Company Profile

CIK0001832038

ISINUS00534A1025

CUSIP00534A102

Phone781 819 0080

Address1601 Trapelo Road, Waltham, MA, 02451, US

SEC EDGAR